Clinical Study
Stem Cell Mobilization with G-CSF versus Cyclophosphamide plus G-CSF in Mexican Children
Table 1
Clinical characteristics of the patients.
| | Number | Age (years) | Sex | Weight (Kg.) | Diagnosis | |
| | 1 | 3 | M | 15 | WT S-IV | 1°CR | | 2 | 10 | F | 39 | LMA-M2 | 2°CR | | 3 | 16 | M | 38 | HD S-IVB | 2°CR | | 4 | 7 | F | 22 | LMA-M1 | 1°CR | | 5 | 3 | F | 15 | LAL-L1 t(9,22) | 1°CR | | 6 | 3 | M | 17 | LAL-L1 t(4:11) | 1°CR | | 7 | 9 | F | 32 | LAL-L1 t(9,22) | 1°CR | | 8 | 12 | M | 32 | HD S-IVB | 2°CR | | 9 | 16 | M | 55 | LAL-L2 t(9,22) | 1°CR | | 10 | 11 | M | 56 | LMA-M4 | 1°CR | | 11 | 16 | M | 43 | LAL-L1 t(9:22) | 2°CR | | 12 | 2 | M | 13 | NBL S-IV | 3°CR | | 13 | 8 | F | 29 | LAL-L2 t(9,22) | 1°CR | | 14 | 8 | M | 26 | LMA-M4 | 1°CR | | 15 | 9 | F | 22 | WT S-IV | 3°CR | | 16 | 4 | M | 21 | LAL-L1 t(9,22) | 1°CR | | 17 | 6 | M | 25 | LMA-M2 | 2°CR | | 18 | 5 | F | 22 | WT S-IV | 2°CR | | 19 | 7 | F | 21 | LMA-M1 | 2°CR | | 20 | 10 | M | 38 | LAL-L1 t(9,22) | 1°CR | | 21 | 8 | M | 25 | LAL-L1 t(9,22) | 1°CR | | 22 | 13 | M | 31 | HD S-IVB | 2°CR | | 23 | 6 | F | 26 | LAL-L1 t(9,22) | 1°CR |
|
|
HD: Hodgkin disease, WT: Wilms’ tumor, LMA: myeloblastic acute leukemia, LAL: lymphoblastic acute leukemia, NBL: neuroblastoma, CR: complete remission, and S: stage.
|
